earnings call
Lician Pro · $19.99/mo or $149/yr · AAPL vs MSFT
Bio-Rad Laboratories (BIO) SEC filings
Bio-Rad Laboratories (BIO) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.
Those exhibit numbers sit next to the income-statement cache: Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. BIO currently screens at trailing P/E 44.8. The BIO filings page is the source view; the stock page is the research view.
EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Bio-Rad Laboratories said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.
Earnings & events
All eventsearnings call
Event insights for BIO — what management said, what changed, and why it matters.
No cached SEC filings for BIO yet. When an 8-K lands, this page will list it.
These filings as JSON? API free 100/dayBIO SEC filings FAQ
What events are listed on the BIO SEC page?
Cached event headlines on this Bio-Rad Laboratories (BIO) SEC page: "BIO earnings". Events: https://lician.com/sec/bio
What is BIO's P/E ratio?
Bio-Rad Laboratories (BIO) trailing P/E is 44.8 on the latest cached fundamentals snapshot.
What are BIO's latest revenue and net income?
Latest cached Bio-Rad Laboratories (BIO) revenue for Dec 31, 2025 was $2.58B. Net income was $759.9M. Statements: https://lician.com/financials/bio